Pharmaceutical giant Eli Lilly has launched donanemab in the Indian market under the brand name Lormalzi. The once-a-month 350 mg infusion has been shown to slow the progression of the disease by dissolving the amyloid beta protein plaques in the brain, proven to be a classical sign of the neurodegenerative disease.
The innovative drug - third to be approved for the disease by the US Food and Drug Administration (USFDA) and the first one to be launched in India - will be prohibitively expensive. A single dose of the drug might cost Rs.91,688. However, Eli Lilly will soon begin an access programme to ensure that patients can get the drug at lower prices.
Tailpiece.
Got up at 5, sent the messages, opened up the house for the day, lit up the puja room lamp and switched on the hymns on the home theatre.
Blood drawal for finding out my Blood Sugars - Fasting and Post Prandial, Hb and LFT. Got the results at 12. My readings are under control, phew!
Walked on the courtyard; recited my prayers and carried out my exercise regimen. The AM dropped by to see our new car.
Lekha's aarathi by the silver coin, today being the 1st of the Malayalam month of Edavam.
Worked on my laptop.
Lunch, Lekha had made a lovely fish curry. Saw the last and final episode of "Snehakkoottu" but didn't see the end as I'd gone out to meet Shebir, the bakery owner followed by siesta.
Aniyan also is coming to New Delhi for the book release.
Went to town to buy a gift for us for our 35th wedding anniversary.
A quiet evening thereafter.